Clinical Trials: Psychotropic Drugs
- Alprazolam 53 studies
- Amitriptyline 65 studies
- Amitriptyline, perphenazine drug combination 65 studies
- Anti-Anxiety Agents 748 studies
- Antidepressive Agents 1871 studies
- Antidepressive Agents, Second-Generation 936 studies
- Antidepressive Agents, Tricyclic 200 studies
- Antimanic Agents 574 studies
- Antipsychotic Agents 1805 studies
- Aripiprazole 256 studies
- Asenapine 39 studies
- Azaperone 1 study
- Bupropion 219 studies
- Buspirone 23 studies
- Carbamazepine 94 studies
- Chlordiazepoxide 4 studies
- Chlorpromazine 9 studies
- Chlorprothixene 1 study
- Citalopram 376 studies
- Clomipramine 16 studies
- Clopenthixol 1 study
- Clorazepate Dipotassium 2 studies
- Clozapine 83 studies
- Cyclobenzaprine 18 studies
- Desipramine 33 studies
- Diazepam 44 studies
- Doxepin 6 studies
- Droperidol 11 studies
- Duloxetine 202 studies
- Estazolam 3 studies
- Etazolate 1 study
- Fluoxetine 153 studies
- Flupenthixol 6 studies
- Flupenthixol decanoate 6 studies
- Fluphenazine 9 studies
- Fluphenazine depot 9 studies
- Fluphenazine enanthate 9 studies
- Fluspirilene 3 studies
- Fluvoxamine 20 studies
- Gabapentin 176 studies
- Gepirone 1 study
- Hallucinogens 91 studies
- Haloperidol 94 studies
- Haloperidol decanoate 94 studies
- Honokiol 1 study
- Hypericin 2 studies
- Imipramine 21 studies
- Lithium 160 studies
- Lithium Carbonate 160 studies
- Lorazepam 78 studies
- Loxapine 18 studies
- Lysergic Acid Diethylamide 1 study
- Methotrimeprazine 2 studies
- Metylperon 2 studies
- Mianserin 30 studies
- Midazolam 272 studies
- Milnacipran 42 studies
- Mirtazapine 53 studies
- Moclobemide 2 studies
- Molindone 3 studies
- N,N-Dimethyltryptamine 2 studies
- N-Methyl-3,4-methylenedioxyamphetamine 23 studies
- Nabilone 14 studies
- Nefazodone 5 studies
- Nefiracetam 1 study
- Nitrazepam 4 studies
- Nortriptyline 36 studies
- O-desmethylvenlafaxine 52 studies
- Olanzapine 309 studies
- Ondansetron 175 studies
- Oxazepam 2 studies
- Paroxetine 175 studies
- Perphenazine 56 studies
- Phenelzine 3 studies
- Pimozide 3 studies
- Pipamperone 3 studies
- Prochlorperazine 16 studies
- Protriptyline 2 studies
- Psilocybine 6 studies
- Quetiapine 327 studies
- Raclopride 16 studies
- Reboxetine 24 studies
- Reserpine 5 studies
- Risperidone 480 studies
- Ritanserin 1 study
- Rolipram 4 studies
- Sch 39166 4 studies
- Sertindole 13 studies
- Sertraline 205 studies
- Sibutramine 32 studies
- Sulpiride 12 studies
- Sultopride 28 studies
- Temazepam 7 studies
- Tetrahydrocannabinol 72 studies
- Thioridazine 3 studies
- Thiothixene 2 studies
- Tianeptine 2 studies
- Tiapride 4 studies
- Tofisopam 2 studies
- Tranquilizing Agents 2556 studies
- Tranylcypromine 11 studies
- Trazodone 22 studies
- Triazolam 7 studies
- Trifluoperazine 2 studies
- Tryptophan 25 studies
- Valproic Acid 258 studies
- Venlafaxine 140 studies
- Ziprasidone 119 studies
- Zotepine 4 studies
- 2,5-Dimethoxy-4-Methylamphetamine 1 study
- 3,4-Methylenedioxyamphetamine 21 studies
- 5-Hydroxytryptophan 7 studies
- 9-hydroxy-risperidone 128 studies
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/browse/intr_cat_PsychDr
